MANCHESTER, UK and HAMBURG, Germany, May 28, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced the acquisition of all shares in Euprotec Ltd, a UK-based specialist contract research organisation. Euprotec is a recognised leader in anti-infective drug discovery services. With a comprehensive portfolio of assays and disease models, underpinned by internationally recognised expertise, the company supports each stage of anti-infective drug discovery and development programmes from discovery through to late stage pre-clinical investigation and clinical proof-of-concept studies.
Help employers find you! Check out all the jobs and post your resume.
